Company Analysis

Cingulate Inc. (CING)

Nasdaq: CING · Pharmaceutical Preparations · Kansas City, KS · filing with the SEC since 2021
Grade3.8
◀ Past 3.0● Present 1.8▶ Future 6.0
7 est.

Filings

319 filings since 2017 beside 175 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 44 days after the quarter ended. The proxy statement was last filed May 29, 2026.

Filings a yearinsider forms included
7268911256771
202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 19 times in the last 36 months, the newest Oct 2, 2026.Listing warning from its exchange (8-K item 3.01): 5 times in the last 36 months, the newest Aug 7, 2024.SEC letters: 19 in the last 36 months, the newest Apr 22, 2026.A late-filing notice, Form NT 10-Q, filed Aug 15, 2025.
Insider forms 175

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Oct 2, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Sep 30, 2026
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 23, 2026 8-K item 5.02 Officer or director change · Current report Jul 17, 2026
Jul 15, 2026 S-8 Employee stock plan registration
Jul 14, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Jul 9, 2026
Jul 2, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Jun 30, 2026
Jun 16, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 2, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 29, 2026 ARS Annual report to shareholders Dec 31, 2025
May 29, 2026 DEFA14A Extra proxy material
May 29, 2026 DEF 14A Proxy statement
May 19, 2026 8-K item 5.02 Officer or director change · Current report May 18, 2026
May 18, 2026 PRE 14A Preliminary proxy statement
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 14, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 28, 2026 424B3 Shelf offering
Apr 24, 2026 EFFECT Registration effective
Apr 22, 2026 CORRESP Reply to the SEC
Apr 17, 2026 UPLOAD SEC comment letter
Apr 14, 2026 S-3 Shelf registration
Apr 2, 2026 8-K item 5.02 Officer or director change · Current report Mar 27, 2026
Mar 27, 2026 424B3 Shelf offering
Mar 26, 2026 EFFECT Registration effective
Mar 26, 2026 CORRESP Reply to the SEC
Mar 26, 2026 SCHEDULE 13D/A Activist holder update, amended
Mar 24, 2026 EFFECT Registration effective
Mar 24, 2026 8-K items 1.01, 5.07 Major agreement signed; Shareholder vote · Current report
Mar 24, 2026 424B3 Shelf offering
Mar 24, 2026 UPLOAD SEC comment letter
Mar 23, 2026 CORRESP Reply to the SEC
Mar 23, 2026 S-3/A Shelf registration, amended
Mar 20, 2026 S-3 Shelf registration
Mar 18, 2026 DEFA14A Extra proxy material
Mar 18, 2026 10-K Annual report Dec 31, 2025
Mar 18, 2026 8-K items 2.02, 8.01, 9.01 Results released; Other event · Current report
Mar 2, 2026 DEF 14A Proxy statement
Feb 18, 2026 PRE 14A Preliminary proxy statement
Feb 17, 2026 8-K items 3.02, 5.02, 7.01, 8.01, 9.01 Shares sold without registration; Officer or director change; Investor disclosure (Regulation FD); Other event · Current report Feb 13, 2026
40 of 319 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CING · research, not advice